Fig. 3From: Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrialsDifference between tumor size according to imaging and residual tumor size versus histological tumor size. Data are shown for all patients with MRI (a) and US (e) and for HR+/HER2+ (b, f), HR−/HER2− (c, g), and HR−/HER2+ tumors (d, h). Quadratic curve was fitted using the least-squares method; shaded areas represent the 95% confidence interval for fitted curvesBack to article page